Over the last few years, public awareness of ADHD has increased significantly. More and more diagnoses of hyperkinetic disorders are being made, and there is a growing understanding of the problems arising from this condition. In addition to these developments, there have also been changes in the treatment options for ADHD – one such development is guanfacine, which has only recently become available on the Polish market.